8,605
Participants
Start Date
March 31, 2013
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Risk of seizure
Patients newly prescribed PPI and H2RA, respectively
Research Site, Madrid
Lead Sponsor
AstraZeneca
INDUSTRY